Clinical Report: Platelet-Rich Plasma Reduces Pain After Tonsillectomy
Overview
Topical autologous platelet-rich plasma (PRP) applied during tonsillectomy significantly reduces postoperative pain and enhances wound healing compared to control treatment. A randomized controlled trial involving 200 patients demonstrated lower pain scores and improved healing outcomes in the PRP group.
Background
Postoperative pain management after tonsillectomy is crucial for patient recovery and quality of life. Traditional analgesic regimens often rely on nonopioid medications, but the introduction of biologics like PRP may offer new avenues for enhancing recovery. Understanding the efficacy of PRP in this context is essential for optimizing postoperative care.
Data Highlights
Outcome
PRP Group
Control Group
Average Pain Score Reduction (VAS)
0.8 points
Control
Complete Mucosal Healing by Day 14
78%
59%
Secondary Hemorrhage Rate
2%
5.2%
Key Findings
PRP treatment resulted in significantly lower pain scores over the first 10 days post-tonsillectomy.
Healing scores were significantly improved at postoperative days 7, 10, and 14 in the PRP group.
Complete mucosal healing by day 14 was observed in 78% of PRP-treated patients compared to 59% in the control group.
No serious adverse events or infections were reported in either group.
Use of rescue analgesia was numerically lower in the PRP group, although not statistically significant.
Clinical Implications
The findings suggest that intraoperative application of PRP may be a beneficial adjunct to standard care in tonsillectomy, potentially leading to reduced pain and faster recovery. Clinicians should consider PRP as a viable option for enhancing postoperative outcomes in tonsillectomy patients.
Conclusion
Intraoperative PRP appears to improve postoperative pain management and wound healing after tonsillectomy. Further multicenter studies are needed to confirm these findings and establish broader clinical guidelines.
